Cleared Traditional

K220112 - AXIOS Stent and Electrocautery-Enhanced Delivery System (FDA 510(k) Clearance)

Sep 2022
Decision
237d
Days
Class 2
Risk

K220112 is an FDA 510(k) clearance for the AXIOS Stent and Electrocautery-Enhanced Delivery System. This device is classified as a Pancreatic Stent, Covered, Metallic, Removable (Class II - Special Controls, product code PCU).

Submitted by Boston Scientific Corporation (Marlboro, US). The FDA issued a Cleared decision on September 7, 2022, 237 days after receiving the submission on January 13, 2022.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5015. To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts.

Submission Details

510(k) Number K220112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2022
Decision Date September 07, 2022
Days to Decision 237 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PCU — Pancreatic Stent, Covered, Metallic, Removable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5015
Definition To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts